Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)

Antzeko izenburuak

• Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)
  nork: Grishma Hirode, et al.
  Argitaratua: (2023)
• Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)
  nork: Edo J. Dongelmans, et al.
  Argitaratua: (2024)
• Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B
  nork: Papatheodoridi, Margarita, et al.
  Argitaratua: (2020)
• Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B‐related hepatocellular carcinoma
  nork: Grace Lai‐Hung Wong, et al.
  Argitaratua: (2016)
• Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues
  nork: Chen, Chien-Hung, et al.
  Argitaratua: (2014)